These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 35405281)

  • 1. Mixing of dry powders for inhalation: A review.
    Spahn JE; Zhang F; Smyth HDC
    Int J Pharm; 2022 May; 619():121736. PubMed ID: 35405281
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigations on the Mechanism of Magnesium Stearate to Modify Aerosol Performance in Dry Powder Inhaled Formulations.
    Jetzer MW; Schneider M; Morrical BD; Imanidis G
    J Pharm Sci; 2018 Apr; 107(4):984-998. PubMed ID: 29247741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Agglomerate behaviour of fluticasone propionate within dry powder inhaler formulations.
    Le VN; Robins E; Flament MP
    Eur J Pharm Biopharm; 2012 Apr; 80(3):596-603. PubMed ID: 22198291
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent developments in lactose blend formulations for carrier-based dry powder inhalation.
    Hebbink GA; Jaspers M; Peters HJW; Dickhoff BHJ
    Adv Drug Deliv Rev; 2022 Oct; 189():114527. PubMed ID: 36070848
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The influence of high shear mixing on ternary dry powder inhaler formulations.
    Hertel M; Schwarz E; Kobler M; Hauptstein S; Steckel H; Scherließ R
    Int J Pharm; 2017 Dec; 534(1-2):242-250. PubMed ID: 29051120
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of mixing on the dispersibility of adhesive mixtures for inhalation. Comparison of high shear and Turbula mixers.
    Thalberg K; Ivarsson L; Svensson M; Elfman P; Ohlsson A; Stuckel J; Lyberg AM
    Eur J Pharm Sci; 2024 Feb; 193():106679. PubMed ID: 38128841
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A New Role of Fine Excipient Materials in Carrier-Based Dry Powder Inhalation Mixtures: Effect on Deagglomeration of Drug Particles During Mixing Revealed.
    Shalash AO; Elsayed MMA
    AAPS PharmSciTech; 2017 Nov; 18(8):2862-2870. PubMed ID: 28421352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Formulating powder-device combinations for salmeterol xinafoate dry powder inhalers.
    Hassoun M; Ho S; Muddle J; Buttini F; Parry M; Hammond M; Forbes B
    Int J Pharm; 2015 Jul; 490(1-2):360-7. PubMed ID: 25987210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exploring the influence of magnesium stearate content and mixing modality on the rheological properties and in vitro aerosolization of dry powder inhaler.
    Li J; Ma S; He X; Sun Y; Zhang X; Guan J; Mao S
    Int J Pharm; 2023 Jul; 642():123179. PubMed ID: 37364785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of a Rational Design Space for Optimizing Mixing Conditions for Formation of Adhesive Mixtures for Dry-Powder Inhaler Formulations.
    Sarkar S; Minatovicz B; Thalberg K; Chaudhuri B
    J Pharm Sci; 2017 Jan; 106(1):129-139. PubMed ID: 27546350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of high shear blending on distribution of magnesium stearate on lactose for dry powder inhaled formulations.
    Welle A; Mehta M; Marek K; Peters H; van der Wel P; Imole O
    Int J Pharm; 2023 Nov; 647():123503. PubMed ID: 37827391
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Recent progress of dry powder inhalation of proteins and peptides].
    Zhou JY; Zhang L; Mao SR
    Yao Xue Xue Bao; 2015 Jul; 50(7):814-23. PubMed ID: 26552141
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dry powder inhalers: a brief overview of the drug detachment techniques.
    Mehta PP
    Ther Deliv; 2020 Mar; 11(3):139-143. PubMed ID: 31914863
    [No Abstract]   [Full Text] [Related]  

  • 14. Insights into the potential of rheological measurements in development of dry powder inhalation formulations.
    Almansour K; Alfagih IM; Shalash AO; Brockbank K; Ali R; Freeman T; Elsayed MMA
    Int J Pharm; 2022 Feb; 614():121407. PubMed ID: 34942326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Controlling the performance of adhesive mixtures for inhalation using mixing energy.
    Thalberg K; Papathanasiou F; Fransson M; Nicholas M
    Int J Pharm; 2021 Jan; 592():120055. PubMed ID: 33176199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of lactose carrier on the powder behavior and aerodynamic performance of bosentan microparticles for dry powder inhalation.
    Lee HJ; Lee HG; Kwon YB; Kim JY; Rhee YS; Chon J; Park ES; Kim DW; Park CW
    Eur J Pharm Sci; 2018 May; 117():279-289. PubMed ID: 29510172
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of Granulated Lactose as a Carrier for Dry Powder Inhaler Formulations 2: Effect of Drugs and Drug Loading.
    Du P; Du J; Smyth HDC
    J Pharm Sci; 2017 Jan; 106(1):366-376. PubMed ID: 27939234
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insights into the roles of carrier microstructure in adhesive/carrier-based dry powder inhalation mixtures: Carrier porosity and fine particle content.
    Shalash AO; Molokhia AM; Elsayed MM
    Eur J Pharm Biopharm; 2015 Oct; 96():291-303. PubMed ID: 26275831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Relationship Between the Permeability and the Performance of Carrier-Based Dry Powder Inhalation Mixtures: New Insights and Practical Guidance.
    Shalash AO; Khalafallah NM; Molokhia AM; Elsayed MMA
    AAPS PharmSciTech; 2018 Feb; 19(2):912-922. PubMed ID: 29063377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of a novel method for the continuous blending of carrier-based dry powders for inhalation using a co-rotating twin-screw extruder.
    Spahn JE; Hefnawy A; Smyth HDC; Zhang F
    Int J Pharm; 2022 Jul; 623():121914. PubMed ID: 35716975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.